India witnessed an increase of 12,428 new COVID-19 cases in a day, the lowest in 238 days, while active cases declined to 1,63,816, according to data updated by the Union Health Ministry on Tuesday. Huh.
With the fresh cases, the total tally rose to 3,42,02,202 while the death toll climbed to 4,55,068 with 356 fresh fatalities, as per the data updated at 8 am.
The daily increase in new coronavirus infections has been below 30,000 for 31 straight days and less than 50,000 daily new cases have been reported for 120 consecutive days.
Read also | Vaccination milestones and distant goals
Here are the latest updates:
Brazil
Brazilian senators called for COVID . but recommended Bolsonaro’s allegations
A Brazilian Senate committee recommended Tuesday that President Jair Bolsonaro face a series of criminal indictments for actions and omissions related to the world’s second-highest COVID-19 death toll.
The 7-to-4 vote was the culmination of a six-month committee investigation into the government’s handling of the pandemic. It formally approved a report calling on prosecutors to prosecute Bolsonaro on charges ranging from charlatanism to the misuse of public funds and crimes against humanity, and in doing so he has been charged with over 600,000 COVID-19 deaths in Brazil. 19 accounted for many of the deaths. – AP
West Bengal
Bengal’s decision to reopen schools, colleges widely welcomed
West Bengal verdict Colleges and schools to reopen from 15 November Widely welcomed by teachers, students and doctors alike, many said the move should have come earlier and these institutions should have a mechanism for early detection of COVID-19 cases.
“In the US and Europe, the effects of the closure of educational institutions have been extensively studied and are of the view that [the long closure] Life expectancy of students has decreased and economic damage has been done which will take about 70 years to recover. We have to remember that the shutdown in India has been very long and hence the impact is going to be huge,” said Dr Arjun Dasgupta, one of the leading ENT specialists in Kolkata. Hindu.
America
US FDA panel endorses Pfizer’s low-dose COVID-19 vaccine for children
The US moves one step closer to expanding COVID-19 vaccination to millions more children Tuesday, October 26, 2021, as a panel of government advisors endorses child-sized doses shots of pfizer For 5- to 11-year-olds.
A Food and Drug Administration advisory panel voted unanimously, with one refrain, that the vaccine’s benefits in preventing COVID-19 in that age group outweigh any potential risks — including the heart-related side effects that may be associated with their Despite are very rare in teens and young adults. Use of too high shot dosage. – AP
Covaxin nod: WHO wants more data
The World Health Organization’s technical advisory group on Tuesday sought “additional clarification” from Bharat Biotech for its COVID-19 vaccine Covaxin, to conduct a final “risk-benefit assessment” to list the emergency use of the vaccine.
The Technical Advisory Group will now meet on November 3 for the final evaluation.
Hyderabad-based Bharat Biotech had submitted an EOI (Expression of Interest) to WHO for the Emergency Use List (EUL) of Covaxin on 19 April. – PTI
.